Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 9 studies | 25% ± 10% | |
| endothelial cell of artery | 8 studies | 22% ± 5% | |
| oligodendrocyte | 8 studies | 26% ± 9% | |
| kidney loop of Henle epithelial cell | 6 studies | 41% ± 13% | |
| kidney distal convoluted tubule epithelial cell | 5 studies | 50% ± 20% | |
| capillary endothelial cell | 4 studies | 25% ± 5% | |
| renal principal cell | 4 studies | 56% ± 27% | |
| kidney connecting tubule epithelial cell | 3 studies | 70% ± 2% | |
| podocyte | 3 studies | 59% ± 11% | |
| extravillous trophoblast | 3 studies | 33% ± 22% | |
| epithelial cell | 3 studies | 35% ± 4% |
Insufficient scRNA-seq data for expression of AIF1L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 12186.83 | 2628 / 2642 | 99% | 121.15 | 699 / 705 |
| kidney | 100% | 30986.37 | 89 / 89 | 88% | 128.81 | 792 / 901 |
| thymus | 100% | 12510.12 | 651 / 653 | 84% | 73.65 | 511 / 605 |
| breast | 97% | 6965.77 | 446 / 459 | 72% | 39.27 | 807 / 1118 |
| skin | 58% | 1604.54 | 1050 / 1809 | 86% | 83.25 | 405 / 472 |
| uterus | 58% | 1513.18 | 99 / 170 | 58% | 20.44 | 268 / 459 |
| ovary | 16% | 401.94 | 29 / 180 | 95% | 67.45 | 410 / 430 |
| esophagus | 74% | 6131.59 | 1064 / 1445 | 28% | 9.45 | 52 / 183 |
| eye | 0% | 0 | 0 / 0 | 100% | 72.60 | 80 / 80 |
| spleen | 100% | 30095.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| prostate | 24% | 548.57 | 60 / 245 | 75% | 16.52 | 379 / 502 |
| adipose | 97% | 6735.81 | 1166 / 1204 | 0% | 0 | 0 / 0 |
| lung | 55% | 1373.71 | 316 / 578 | 36% | 10.62 | 413 / 1155 |
| blood vessel | 85% | 6513.99 | 1132 / 1335 | 0% | 0 | 0 / 0 |
| heart | 65% | 2197.71 | 559 / 861 | 0% | 0 | 0 / 0 |
| bladder | 38% | 1075.71 | 8 / 21 | 21% | 6.63 | 105 / 504 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 10.62 | 21 / 45 |
| intestine | 24% | 612.46 | 233 / 966 | 10% | 3.23 | 54 / 527 |
| adrenal gland | 6% | 117.74 | 16 / 258 | 28% | 13.18 | 64 / 230 |
| stomach | 24% | 587.33 | 87 / 359 | 9% | 3.85 | 25 / 286 |
| pancreas | 2% | 40.62 | 7 / 328 | 15% | 3.10 | 27 / 178 |
| liver | 0% | 0 | 0 / 226 | 9% | 4.31 | 37 / 406 |
| muscle | 8% | 165.51 | 64 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.87 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051017 | Biological process | actin filament bundle assembly |
| GO_0097178 | Biological process | ruffle assembly |
| GO_0032587 | Cellular component | ruffle membrane |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005884 | Cellular component | actin filament |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0051015 | Molecular function | actin filament binding |
| Gene name | AIF1L |
| Protein name | Allograft inflammatory factor 1 like Allograft inflammatory factor 1-like (Ionized calcium-binding adapter molecule 2) |
| Synonyms | C9orf58 UNQ672/PRO1306 IBA2 |
| Description | FUNCTION: Actin-binding protein that promotes actin bundling. May neither bind calcium nor depend on calcium for function. . |
| Accessions | ENST00000372302.5 [Q9BQI0-3] ENST00000372301.2 A6PVM9 H7C605 ENST00000372300.5 [Q9BQI0-4] Q5JUP3 ENST00000372298.1 Q9BQI0 Q5JUP1 ENST00000372309.7 [Q9BQI0-2] ENST00000372297.6 ENST00000372314.3 ENST00000247291.8 [Q9BQI0-1] |